Johnson & Johnson Reports Strong Q1 Performance

Johnson & Johnson (J&J) unveiled its first-quarter fiscal 2025 results, showcasing a robust 2.4% year-over-year sales growth to $21.9 billion, surpassing market expectations.

Earnings Per Share and Net Earnings Skyrocket

The company's diluted earnings per share experienced an extraordinary 238.8% increase to $4.54, while net earnings climbed to $11 billion, marking a 237.9% surge from the previous year.

Leadership's Optimistic Outlook

"The strength of Johnson & Johnson’s diversified portfolio was evident this quarter, with strong operational sales growth bolstering our confidence in the 2025 guidance," stated Chairman and CEO Joaquin Duato. Following the announcement, J&J's stock price rose by 0.43% in premarket trading, reaching $155.03 per share.